115 related articles for article (PubMed ID: 8980244)
21. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
22. Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features.
Ishikawa Y; Horiguchi J; Toya H; Nakajima H; Hayashi M; Tagaya N; Takeyoshi I; Oyama T
Cancer Sci; 2011 Mar; 102(3):656-62. PubMed ID: 21214677
[TBL] [Abstract][Full Text] [Related]
23. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
24. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
[TBL] [Abstract][Full Text] [Related]
25. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.
García Fernández A; Chabrera C; García Font M; Fraile M; Lain JM; Barco I; González C; Gónzalez S; Reñe A; Veloso E; Cassadó J; Pessarrodona A; Giménez N
Breast; 2013 Oct; 22(5):902-7. PubMed ID: 23684000
[TBL] [Abstract][Full Text] [Related]
26. Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis.
Sugawara I; Hirakoshi J; Masunaga A; Itoyama S; Sakakura T
Invasion Metastasis; 1991; 11(6):325-31. PubMed ID: 1726610
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma.
Sis B; Sağol O; Küpelioğlu A; Sokmen S; Terzi C; Fuzun M; Ozer E; Bishop P
Pathol Res Pract; 2004; 200(5):379-87. PubMed ID: 15239346
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
[TBL] [Abstract][Full Text] [Related]
29. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
30. HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer.
Kamei M; Yamashita S; Tokuishi K; Hashioto T; Moroga T; Suehiro S; Ono K; Miyawaki M; Takeno S; Yamamoto S; Kawahara K
Anticancer Res; 2010 Nov; 30(11):4779-83. PubMed ID: 21115941
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.
Shabo I; Stål O; Olsson H; Doré S; Svanvik J
Int J Cancer; 2008 Aug; 123(4):780-6. PubMed ID: 18506688
[TBL] [Abstract][Full Text] [Related]
32. Value of tenascin-C content and association with clinicopathological parameters in uterine cervical lesions.
Buyukbayram H; Arslan A
Int J Cancer; 2002 Aug; 100(6):719-22. PubMed ID: 12209613
[TBL] [Abstract][Full Text] [Related]
33. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
[TBL] [Abstract][Full Text] [Related]
34. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
Hindermann W; Berndt A; Borsi L; Luo X; Hyckel P; Katenkamp D; Kosmehl H
J Pathol; 1999 Dec; 189(4):475-80. PubMed ID: 10629546
[TBL] [Abstract][Full Text] [Related]
36. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
37. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
Cefaro GA; Genovesi D; Trignani M; DI Nicola M
Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
40. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
